176 related articles for article (PubMed ID: 12975490)
1. Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations.
Chi L; Reith ME
J Pharmacol Exp Ther; 2003 Nov; 307(2):729-36. PubMed ID: 12975490
[TBL] [Abstract][Full Text] [Related]
2. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
3. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
Daws LC; Callaghan PD; Morón JA; Kahlig KM; Shippenberg TS; Javitch JA; Galli A
Biochem Biophys Res Commun; 2002 Feb; 290(5):1545-50. PubMed ID: 11820798
[TBL] [Abstract][Full Text] [Related]
4. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
Wersinger C; Vernier P; Sidhu A
Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
[TBL] [Abstract][Full Text] [Related]
5. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
6. Rapid and reversible effects of methamphetamine on dopamine transporters.
Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
[TBL] [Abstract][Full Text] [Related]
7. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
9. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
Volz TJ; Kim M; Schenk JO
Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of Zn2+ on the kinetics and cocaine inhibition of dopamine transport by the human and rat dopamine transporters.
Bjorklund NL; Volz TJ; Schenk JO
Eur J Pharmacol; 2007 Jun; 565(1-3):17-25. PubMed ID: 17408612
[TBL] [Abstract][Full Text] [Related]
11. Synaptosomal dopamine uptake in rat striatum following controlled cortical impact.
Wilson MS; Chen X; Ma X; Ren D; Wagner AK; Reynolds IJ; Dixon CE
J Neurosci Res; 2005 Apr; 80(1):85-91. PubMed ID: 15704194
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
[TBL] [Abstract][Full Text] [Related]
13. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm.
Byas-Smith MG; Li J; Szlam F; Eaton DC; Votaw JR; Denson DD
Synapse; 2004 Aug; 53(2):68-73. PubMed ID: 15170819
[TBL] [Abstract][Full Text] [Related]
14. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.
Sorkina T; Hoover BR; Zahniser NR; Sorkin A
Traffic; 2005 Feb; 6(2):157-70. PubMed ID: 15634215
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
16. Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates.
Zhen J; Chen N; Reith ME
Neuropharmacology; 2005 Nov; 49(6):769-79. PubMed ID: 16122767
[TBL] [Abstract][Full Text] [Related]
17. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.
Zhu J; Bardo MT; Bruntz RC; Stairs DJ; Dwoskin LP
Eur J Neurosci; 2007 Aug; 26(3):717-28. PubMed ID: 17651428
[TBL] [Abstract][Full Text] [Related]
18. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content.
Bemis JC; Seegal RF
Toxicol Sci; 2004 Aug; 80(2):288-95. PubMed ID: 15115888
[TBL] [Abstract][Full Text] [Related]
19. D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by alpha-methyl-p-tyrosine.
Han S; Rowell PP; Carr LA
Res Commun Mol Pathol Pharmacol; 1999; 104(3):331-8. PubMed ID: 10741383
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
